Skip to main content
Livermore
Livermore
ZHEN

Cito Capital Group, LLC

SEC CIK
0001722439
Latest filing
Aug 14, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Cito Capital Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
4,000
Value
$2.49M
% of portfolio
0.7%
Quarters held
22
Since Q1 2021
Holdings of REGN by Cito Capital Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,000$2.49M0.7%+160+4.2%AddedHolders
Q1 20263,840$2.97M0.9%00.0%UnchangedHolders
Q4 20253,840$2.96M0.9%+600+18.5%AddedHolders
Q3 20253,240$1.82M0.5%00.0%UnchangedHolders
Q2 20253,240$1.70M0.6%+1,200+58.8%AddedHolders
Q1 20252,040$1.29M0.5%00.0%UnchangedHolders
Q4 20242,040$1.45M0.5%00.0%UnchangedHolders
Q3 20242,040$2.15M0.8%+500+32.5%AddedHolders
Q2 20241,540$1.62M0.6%+500+48.1%AddedHolders
Q1 20241,040$1.00M0.4%00.0%UnchangedHolders
Q4 20231,040$913.0K0.4%00.0%UnchangedHolders
Q3 20231,040$856.0K0.4%00.0%UnchangedHolders
Q2 20231,040$747.0K0.3%−7−0.7%ReducedHolders
Q1 20231,047$860.0K0.4%+7+0.7%AddedHolders
Q4 20221,040$750.0K0.4%00.0%UnchangedHolders
Q3 20221,040$716.0K0.4%−1,000−49.0%ReducedHolders
Q2 20222,040$1.21M0.7%−500−19.7%ReducedHolders
Q1 20222,540$1.77M0.8%00.0%UnchangedHolders
Q4 20212,540$1.60M0.7%−560−18.1%ReducedHolders
Q3 20213,100$1.88M0.9%−500−13.9%ReducedHolders
Q2 20213,600$2.01M0.9%00.0%UnchangedHolders
Q1 20213,600$1.70M0.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.